CCVAX | VSMAX | CCVAX / VSMAX | |
Total Expense Ratio | 1.19 | 0.05 | 2,380% |
Annual Report Gross Expense Ratio | 1.19 | 0.05 | 2,380% |
Fund Existence | 21 years | 25 years | - |
Gain YTD | -4.899 | 5.599 | -87% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.37B | 162B | 1% |
Annual Yield % from dividends | 0.14 | 1.34 | 11% |
Returns for 1 year | -7.09 | 4.95 | -143% |
Returns for 3 years | 19.33 | 42.02 | 46% |
Returns for 5 years | 25.43 | 55.46 | 46% |
Returns for 10 years | 38.34 | 130.86 | 29% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ITHRX | 53.68 | 0.21 | +0.39% |
Hartford Capital Appreciation R3 | |||
IUCEX | 29.49 | 0.08 | +0.27% |
JPMorgan International Focus C | |||
DSMLX | 67.34 | 0.05 | +0.07% |
Touchstone Large Company Growth Instl | |||
MSDOX | 15.53 | N/A | N/A |
Morgan Stanley Emerging Mkt ex China C | |||
MSCYX | 14.84 | -0.03 | -0.20% |
MassMutual Small Cap Gr Eq Svc |